Rocket Pharmaceuticals, Inc. (RCKT) · Insider trading
What Rocket Pharmaceuticals's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$34,400
1 insider, 1 trade
Sold, 12 months
$864,008
6 insiders, 0% under a plan
Net, 12 months
−$829,608
bought less sold
Latest filing
2026-09-15
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Shah GauravCEO | $101,600 | $641,255 | 13 | 2026-08-18 | 1,056,594 |
| Wilson MartinGeneral Counsel | – | $435,162 | 15 | 2026-09-11 | 598,489 |
| Militello JohnSee Remarks | – | $243,988 | 19 | 2026-05-19 | 89,780 |
| Patel KinnariSee Remarks | $99,165 | $138,327 | 5 | 2025-05-20 | 441,927 |
| Schwartz Jonathan DavidSee Remarks | – | $173,884 | 8 | 2025-11-18 | 299,064 |
| Stevens Christopher JamesChief Operating Officer | – | $128,303 | 1 | 2026-08-11 | 505,784 |
| Chaudhuri SarbaniSee Remarks | – | $84,230 | 2 | 2026-08-11 | 262,809 |
| Bjork ElisabethDirector | $68,500 | – | 2 | 2026-01-02 | 50,000 |
| White Mark AndrewSee Remarks | – | $51,220 | 1 | 2024-10-31 | 69,140 |
| Ondrey AaronChief Financial Officer | – | $43,871 | 2 | 2025-07-03 | 128,173 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | Wilson MartinGeneral Counsel | Sale | 75,364 | 3.40 | $256,238 | 598,489 | Form 4 |
| 2026-08-18 | Shah GauravCEO | Sale | 2,293 | 3.38 | $7,750 | 1,056,594 | Form 4 |
| 2026-08-18 | Wilson MartinGeneral Counsel | Sale | 631 | 3.38 | $2,133 | 673,853 | Form 4 |
| 2026-08-13 | Wilson MartinGeneral Counsel | Sale | 3,493 | 3.38 | $11,806 | 674,484 | Form 4 |
| 2026-08-13 | Shah GauravCEO | Sale | 2,837 | 3.38 | $9,589 | 1,058,887 | Form 4 |
| 2026-08-11 | Chaudhuri SarbaniSee Remarks | Sale | 4,701 | 3.50 | $16,454 | 262,809 | Form 4 |
| 2026-08-11 | Stevens Christopher JamesChief Operating Officer | Sale | 36,658 | 3.50 | $128,303 | 505,784 | Form 4 |
| 2026-05-21 | Shah GauravCEO | Sale | 55,684 | 3.09 | $172,064 | 1,061,724 | Form 4 |
| 2026-05-19 | Militello JohnSee Remarks | Sale | 384 | 3.01 | $1,156 | 89,780 | Form 4 |
| 2026-05-19 | Wilson MartinGeneral Counsel | Sale | 662 | 3.01 | $1,993 | 677,977 | Form 4 |
| 2026-05-19 | Shah GauravCEO | Sale | 2,409 | 3.01 | $7,251 | 1,040,918 | Form 4 |
| 2026-05-13 | Militello JohnSee Remarks | Sale | 855 | 3.61 | $3,087 | 90,164 | Form 4 |
| 2026-05-13 | Shah GauravCEO | Sale | 2,728 | 3.61 | $9,848 | 1,043,327 | Form 4 |
| 2026-05-13 | Wilson MartinGeneral Counsel | Sale | 3,361 | 3.61 | $12,133 | 678,639 | Form 4 |
| 2026-05-07 | Chaudhuri SarbaniSee Remarks | Sale | 17,650 | 3.84 | $67,776 | 267,510 | Form 4 |
| 2026-02-18 | Wilson MartinGeneral Counsel | Sale | 1,376 | 3.34 | $4,596 | 682,000 | Form 4 |
| 2026-02-18 | Shah GauravCEO | Sale | 5,990 | 3.34 | $20,007 | 1,046,055 | Form 4 |
| 2026-02-18 | Militello JohnSee Remarks | Sale | 1,157 | 3.34 | $3,864 | 91,019 | Form 4 |
| 2026-02-13 | Shah GauravCEO | Sale | 12,279 | 3.31 | $40,643 | 1,052,045 | Form 4 |
| 2026-02-13 | Militello JohnSee Remarks | Sale | 3,726 | 3.31 | $12,333 | 92,176 | Form 4 |
| 2026-02-13 | Wilson MartinGeneral Counsel | Sale | 12,253 | 3.31 | $40,557 | 683,376 | Form 4 |
| 2026-01-02 | Bjork ElisabethDirector | Buy | 10,000 | 3.44 | $34,400 | 50,000 | Form 4 |
| 2025-11-18 | Wilson MartinGeneral Counsel | Sale | 1,646 | 2.98 | $4,905 | 383,816 | Form 4 |
| 2025-11-18 | Shah GauravDirector, CEO | Sale | 6,276 | 2.98 | $18,702 | 778,296 | Form 4 |
| 2025-11-18 | Schwartz Jonathan DavidSee Remarks | Sale | 2,545 | 2.98 | $7,584 | 299,064 | Form 4 |
| 2025-11-18 | Militello JohnSee Remarks | Sale | 1,086 | 2.98 | $3,236 | 65,920 | Form 4 |
| 2025-10-14 | Militello JohnSee Remarks | Sale | 19,841 | 3.96 | $78,570 | 76,083 | Form 4 |
| 2025-10-14 | Militello JohnSee Remarks | Sale | 5,514 | 3.97 | $21,891 | 70,569 | Form 4 |
| 2025-10-14 | Militello JohnSee Remarks | Sale | 3,005 | 3.97 | $11,930 | 67,564 | Form 4 |
| 2025-10-14 | Militello JohnSee Remarks | Sale | 558 | 3.98 | $2,221 | 67,006 | Form 4 |
| 2025-08-27 | Bjork ElisabethDirector | Buy | 10,000 | 3.41 | $34,100 | 40,000 | Form 4 |
| 2025-08-19 | Wilson MartinGeneral Counsel | Sale | 588 | 3.00 | $1,764 | 135,462 | Form 4 |
| 2025-08-19 | Schwartz Jonathan DavidSee Remarks | Sale | 805 | 3.00 | $2,415 | 221,609 | Form 4 |
| 2025-08-19 | Militello JohnSee Remarks | Sale | 361 | 3.00 | $1,083 | 55,924 | Form 4 |
| 2025-08-18 | Wilson MartinGeneral Counsel | Sale | 1,004 | 3.07 | $3,082 | 136,050 | Form 4 |
| 2025-08-18 | Schwartz Jonathan DavidSee Remarks | Sale | 1,680 | 3.07 | $5,158 | 222,414 | Form 4 |
| 2025-08-18 | Militello JohnSee Remarks | Sale | 699 | 3.07 | $2,146 | 56,285 | Form 4 |
| 2025-08-14 | Wilson MartinGeneral Counsel | Sale | 12,109 | 3.02 | $36,569 | 137,054 | Form 4 |
| 2025-08-14 | Militello JohnSee Remarks | Sale | 7,043 | 3.02 | $21,270 | 56,984 | Form 4 |
| 2025-08-14 | Schwartz Jonathan DavidSee Remarks | Sale | 11,161 | 3.02 | $33,706 | 224,094 | Form 4 |
28 more
| 2025-07-03 | Ondrey AaronChief Financial Officer | Sale | 1,477 | 2.88 | $4,254 | 128,173 | Form 4 |
| 2025-05-20 | Wilson MartinGeneral Counsel | Sale | 587 | 6.45 | $3,786 | 149,163 | Form 4 |
| 2025-05-20 | Shah GauravDirector, CEO | Sale | 2,253 | 6.45 | $14,532 | 786,806 | Form 4 |
| 2025-05-20 | Patel KinnariSee Remarks | Sale | 767 | 6.45 | $4,947 | 441,927 | Form 4 |
| 2025-05-20 | Schwartz Jonathan DavidSee Remarks | Sale | 801 | 6.45 | $5,166 | 235,255 | Form 4 |
| 2025-05-20 | Militello JohnSee Remarks | Sale | 357 | 6.45 | $2,303 | 64,027 | Form 4 |
| 2025-05-16 | Wilson MartinGeneral Counsel | Sale | 946 | 6.53 | $6,177 | 149,750 | Form 4 |
| 2025-05-16 | Shah GauravDirector, CEO | Sale | 3,621 | 6.53 | $23,645 | 789,059 | Form 4 |
| 2025-05-16 | Schwartz Jonathan DavidSee Remarks | Sale | 1,582 | 6.53 | $10,330 | 236,056 | Form 4 |
| 2025-05-16 | Patel KinnariSee Remarks | Sale | 1,409 | 6.53 | $9,201 | 442,694 | Form 4 |
| 2025-05-16 | Militello JohnSee Remarks | Sale | 655 | 6.53 | $4,277 | 64,384 | Form 4 |
| 2025-04-22 | Militello JohnSee Remarks | Sale | 718 | 7.16 | $5,141 | 65,039 | Form 4 |
| 2025-04-10 | Shah GauravDirector, CEO | Buy | 20,000 | 5.08 | $101,600 | 792,680 | Form 4 |
| 2025-04-09 | Patel KinnariSee Remarks | Buyindirect | 21,099 | 4.70 | $99,165 | 26,774 | Form 4 |
| 2025-04-04 | Ondrey AaronChief Financial Officer | Sale | 7,489 | 5.29 | $39,617 | 129,650 | Form 4 |
| 2025-02-25 | Schwartz Jonathan DavidSee Remarks | Sale | 6,532 | 10.58 | $69,109 | 237,638 | Form 4 |
| 2025-02-21 | Shah GauravDirector, CEO | Sale | 16,303 | 10.58 | $172,486 | 772,680 | Form 4 |
| 2025-02-21 | Militello JohnSee Remarks | Sale | 2,737 | 10.58 | $28,957 | 65,757 | Form 4 |
| 2025-02-21 | Wilson MartinGeneral Counsel | Sale | 3,222 | 10.58 | $34,089 | 150,696 | Form 4 |
| 2025-02-21 | Patel KinnariSee Remarks | Sale | 6,078 | 10.58 | $64,305 | 444,103 | Form 4 |
| 2025-01-23 | Militello JohnSee Remarks | Sale | 896 | 10.38 | $9,300 | 48,414 | Form 4 |
| 2024-11-21 | Schwartz Jonathan DavidSee Remarks | Sale | 3,097 | 13.05 | $40,416 | 163,852 | Form 4 |
| 2024-11-21 | Wilson MartinGeneral Counsel | Sale | 1,175 | 13.05 | $15,334 | 63,560 | Form 4 |
| 2024-11-21 | Shah GauravDirector, CEO | Sale | 11,091 | 13.05 | $144,738 | 707,328 | Form 4 |
| 2024-11-21 | Patel KinnariSee Remarks | Sale | 4,588 | 13.05 | $59,873 | 392,395 | Form 4 |
| 2024-11-21 | Militello JohnSee Remarks | Sale | 1,224 | 13.05 | $15,973 | 49,310 | Form 4 |
| 2024-10-31 | Militello JohnSee Remarks | Sale | 917 | 16.63 | $15,250 | 50,534 | Form 4 |
| 2024-10-31 | White Mark AndrewSee Remarks | Sale | 3,080 | 16.63 | $51,220 | 69,140 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
40 × grant or award5 × other3 × option exercise1 × option exercise1 × shares withheld for tax
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-03 | Southwell David PDirector | Other J | +150,000 | – | 204,522 | Form 4 |
| 2026-08-03 | Stevens Christopher JamesChief Operating Officer | Grant or award A | +73,313 | – | 542,442 | Form 4 |
| 2026-06-18 | Boess CarstenDirector | Grant or award A | +22,862 | – | 52,862 | Form 4 |
| 2026-06-18 | Southwell David PDirector | Grant or award A | +22,862 | – | 54,522 | Form 4 |
| 2026-06-18 | Malik Fady IbrahamDirector | Grant or award A | +22,862 | – | 52,862 | Form 4 |
| 2026-06-18 | Dolsten MikaelDirector | Grant or award A | +22,862 | – | 67,082 | Form 4 |
| 2026-06-18 | Fong PeterDirector | Grant or award A | +22,862 | – | 76,195 | Form 4 |
| 2026-06-18 | Wong RoderickDirector, 10% owner | Grant or award A | +27,832 | – | 75,499 | Form 4 |
| 2026-05-21 | Shah GauravCEO | Option exercise M | +76,490 | 1.69 | 1,117,408 | Form 4 |
| 2026-02-11 | Chaudhuri SarbaniSee Remarks | Grant or award A | +125,924 | – | 285,160 | Form 4 |
| 2026-02-11 | Stevens Christopher JamesChief Operating Officer | Grant or award A | +61,963 | – | 469,129 | Form 4 |
| 2026-02-11 | Rizvi Syed Ali-aamirChief Medical Officer | Grant or award A | +61,963 | – | 407,874 | Form 4 |
| 2026-02-11 | Wilson MartinGeneral Counsel | Grant or award A | +311,813 | – | 695,629 | Form 4 |
| 2026-02-11 | Militello JohnSee Remarks | Grant or award A | +29,982 | – | 95,902 | Form 4 |
| 2026-02-11 | Shah GauravCEO | Grant or award A | +286,028 | – | 1,064,324 | Form 4 |
| 2025-11-03 | Wilson MartinGeneral Counsel | Grant or award A | +100,000 | – | 385,462 | Form 4 |
| 2025-10-06 | Rizvi Syed Ali-aamirChief Medical Officer | Grant or award A | +283,018 | – | 283,018 | Form 4 |
| 2025-10-06 | Rizvi Syed Ali-aamirChief Medical Officer | Grant or award A | +62,893 | – | 345,911 | Form 4 |
| 2025-09-24 | Fong PeterDirector | Grant or award A | +23,333 | – | 23,333 | Form 4 |
| 2025-09-24 | Fong PeterDirector | Grant or award A | +30,000 | – | 53,333 | Form 4 |
| 2025-09-19 | Rtw Investments, LPDirector, 10% owner, Other | Option exercise X | +1,000,000 | 40.03 | 19,188,457 | Form 4 |
| 2025-09-19 | Rtw Investments, LPDirector, 10% owner, Other | Other J | −1,000,000 | 3.11 | 18,188,457 | Form 4 |
| 2025-09-19 | Rtw Investments, LPDirector, 10% owner, Other | Option exercise X | +41,000 | 19.09 | 18,229,457 | Form 4 |
| 2025-09-19 | Rtw Investments, LPDirector, 10% owner, Other | Other J | −41,000 | 3.11 | 18,188,457 | Form 4 |
| 2025-09-19 | Rtw Investments, LPDirector, 10% owner, Other | Option exercise X | +59,000 | 17.81 | 18,247,457 | Form 4 |
| 2025-09-19 | Rtw Investments, LPDirector, 10% owner, Other | Other J | −59,000 | 3.11 | 18,188,457 | Form 4 |
| 2025-09-08 | Schwartz Jonathan DavidSee Remarks | Grant or award A | +80,000 | – | 301,609 | Form 4 |
| 2025-09-08 | Wilson MartinGeneral Counsel | Grant or award A | +150,000 | – | 285,462 | Form 4 |
| 2025-09-08 | Militello JohnSee Remarks | Grant or award A | +40,000 | – | 95,924 | Form 4 |
| 2025-08-18 | Shah GauravDirector, CEO | Shares withheld for tax F | −2,234 | 3.05 | 784,572 | Form 4 |
| 2025-08-04 | Stevens Christopher JamesChief Operating Officer | Grant or award A | +407,166 | – | 407,166 | Form 4 |
| 2025-06-18 | Southwell David PDirector | Grant or award A | +30,000 | – | 31,660 | Form 4 |
| 2025-06-18 | Bjork ElisabethDirector | Grant or award A | +30,000 | – | 30,000 | Form 4 |
| 2025-06-18 | Boess CarstenDirector | Grant or award A | +30,000 | – | 30,000 | Form 4 |
| 2025-06-18 | Malik Fady IbrahamDirector | Grant or award A | +30,000 | – | 30,000 | Form 4 |
| 2025-06-18 | Makker GothamDirector | Grant or award A | +30,000 | – | 395,912 | Form 4 |
| 2025-06-18 | Makker GothamDirector | Grant or award A | +19,434 | – | 415,346 | Form 4 |
| 2025-06-18 | Dolsten MikaelDirector | Grant or award A | +30,000 | – | 44,220 | Form 4 |
| 2025-06-18 | Granadillo Pedro PDirector | Grant or award A | +30,000 | – | 30,000 | Form 4 |
| 2025-06-18 | Granadillo Pedro PDirector | Grant or award A | +24,734 | – | 54,734 | Form 4 |
| 2025-06-18 | Pratumsuwan PiratipDirector | Grant or award A | +30,000 | – | 30,000 | Form 4 |
| 2025-06-18 | Wong RoderickDirector, 10% owner | Grant or award A | +30,000 | – | 30,000 | Form 4 |
| 2025-06-18 | Wong RoderickDirector, 10% owner | Grant or award A | +17,667 | – | 47,667 | Form 4 |
| 2025-03-05 | Dolsten MikaelDirector | Other J | +14,220 | – | 14,220 | Form 4 |
| 2025-02-11 | Militello JohnSee Remarks | Grant or award A | +20,080 | – | 68,494 | Form 4 |
| 2025-02-11 | Ondrey AaronChief Financial Officer | Grant or award A | +90,358 | – | 137,139 | Form 4 |
| 2025-02-11 | Patel KinnariSee Remarks | Grant or award A | +57,786 | – | 450,181 | Form 4 |
| 2025-02-11 | Schwartz Jonathan DavidSee Remarks | Grant or award A | +80,318 | – | 252,731 | Form 4 |
| 2025-02-11 | Shah GauravDirector, CEO | Grant or award A | +81,655 | – | 788,983 | Form 4 |
| 2025-02-11 | Wilson MartinGeneral Counsel | Grant or award A | +90,358 | – | 153,918 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.